Evidence of cis-acting regulatory variation in PTPN22 in patients with rheumatoid arthritis.
OBJECTIVES: To assess whether there are cis-regulatory polymorphisms that regulate protein tyrosine phosphatase, non-receptor type 22 (PTPN22) expression in rheumatoid arthritis (RA). METHODS: RNA was extracted from positively selected CD56+, CD8+, and CD4+ mononuclear cells and the 'residual&...
Main Authors: | Harrison, P, Southam, L, Chapman, K, Locklin, R, Sabokbar, A, Wordsworth, B, Pointon, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Differential allelic expression of protein tyrosine phosphatase NonReceptor 22 in rheumatoid arthritis patients
by: Harrison, P, et al.
Published: (2008) -
Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
by: Harrison, P, et al.
Published: (2006) -
The PTPN22 R620W polymorphism - Effects on susceptibility and clinical features on British Caucasian rheumatoid arthritis patients.
by: Harrison, P, et al.
Published: (2005) -
Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis.
by: Harrison, P, et al.
Published: (2008) -
The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples.
by: Rodríguez-Rodríguez, L, et al.
Published: (2011)